CCL2 and gout: In vivo studies suggest that CCL2 attracts monocytes to sites of inflammation in a variety of pathologic conditions, including atherosclerosis [4,5], pulmonary fibrosis and granulomatous lung disease [6], and degenerative and inflammatory arthropathies, including gout [7-9].